COVID-19 vaccine uptake and hesitancy in Chinese patients with asthma

References

• Choi YJ, Park J-Y, Lee HS, Suh J, Song JY, Byun MK, Cho JH, Kim HJ, Lee J-H, Park J-W, et al. Effect of asthma and asthma medication on the prognosis of patients with COVID-19. Eur Respir J 2021;57(3):2002226. doi:10.1183/13993003.02226-2020.
   PubMed Web of Science ®Google Scholar
• Izquierdo JL, Almonacid C, González Y, Del Rio-Bermudez C, Ancochea J, Cárdenas R, Lumbreras S, Soriano JB. The impact of COVID-19 on patients with asthma. Eur Respir J 2021;57(3):2003142. doi:10.1183/13993003.03142-2020.
   PubMed Web of Science ®Google Scholar
• Ren J, Pang W, Luo Y, Cheng D, Qiu K, Rao Y, Zheng Y, Dong Y, Peng J, Hu Y, et al. Impact of allergic rhinitis and asthma on COVID-19 infection, hospitalization, and mortality. J Allergy Clin Immunol Pract 2022;10(1):124–133. doi:10.1016/j.jaip.2021.10.049.
   PubMed Web of Science ®Google Scholar
• Wang K, Wang L, Li M, Xie B, He L, Wang M, Zhang R, Hou N, Zhang Y, Jia F, et al. Real-word effectiveness of global COVID-19 vaccines against SARS-CoV-2 variants: a systematic review and meta-analysis. Front Med (Lausanne) 2022;9:820544. doi:10.3389/fmed.2022.820544.
   PubMed Web of Science ®Google Scholar
• Fisher KA, Bloomstone SJ, Walder J, Crawford S, Fouayzi H, Mazor KM. Attitudes toward a potential SARS-CoV-2 vaccine : a survey of U.S. adults. Ann Intern Med. 2020;173(12):964–973. doi:10.7326/M20-3569.
   PubMed Web of Science ®Google Scholar
• Karafillakis E, Larson HJ ; ADVANCE Consortium. The benefit of the doubt or doubts over benefits? A systematic literature review of perceived risks of vaccines in European populations. Vaccine. 2017;35(37):4840–4850. doi:10.1016/j.vaccine.2017.07.061.
   PubMed Web of Science ®Google Scholar
• Colaneri M, De Filippo M, Licari A, Marseglia A, Maiocchi L, Ricciardi A, Corsico A, Marseglia G, Mondelli MU, Bruno R, et al. COVID vaccination and asthma exacerbation: might there be a link? Int J Infect Dis. 2021;112:243–246. doi:10.1016/j.ijid.2021.09.026.
   PubMed Web of Science ®Google Scholar
• Carroll JK, Arias Hernandez P, Brooks-Greisen A, Carlos Cardet J, Cui J, Ericson B, Fagan M, Fajt ML, Forth VE, Fuhlbrigge AL, et al. Socioeconomic impact of COVID-19 and willingness to be vaccinated in African American/Black and Hispanic/Latinx adults. J Natl Med Assoc 2022;114(2):182–192. doi:10.1016/j.jnma.2021.12.010.
   PubMed Web of Science ®Google Scholar
• Share of people who completed the initial COVID-19 vaccination protocol. https://ourworldindata.org/covid-vaccinations.
   Google Scholar
• Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, Curtis HJ, Mehrkar A, Evans D, Inglesby P, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature 2020;584(7821):430–436. doi:10.1038/s41586-020-2521-4.
   PubMed Web of Science ®Google Scholar
• Liu S, Cao Y, Du T, Zhi Y. Prevalence of comorbid asthma and related outcomes in COVID-19; a systematic review and meta-analysis. J Allergy Clin Immunol Pract 2021;9(2):693–701. doi:10.1016/j.jaip.2020.11.054.
   PubMed Web of Science ®Google Scholar
• Stone CA, Rukasin CRF, Beachkofsky TM, Phillips EJ. Immune-mediated adverse reactions to vaccines. Br J Clin Pharmacol 2019;85(12):2694–2706. doi:10.1111/bcp.14112.
   PubMed Web of Science ®Google Scholar
• Su JR, Moro PL, Ng CS, Lewis PW, Said MA, Cano MV. Anaphylaxis after vaccination reported to the vaccine adverse event reporting system, 1990-2016. J Allergy Clin Immunol 2019;143(4):1465–1473. doi:10.1016/j.jaci.2018.12.1003.
   PubMed Web of Science ®Google Scholar
• Greenhawt M, Abrams EM, Shaker M, Chu DK, Khan D, Akin C, Alqurashi W, Arkwright P, Baldwin JL, Ben-Shoshan M, et al. The risk of allergic reaction to SARS-CoV-2 vaccines and recommended evaluation and management: a systematic review, meta-analysis, GRADE assessment, and international consensus approach. J Allergy Clin Immunol Pract 2021;9(10):3546–3567. doi:10.1016/j.jaip.2021.06.006.
   Web of Science ®Google Scholar
• CDC. COVID-19 Response Team; Food and Drug Administration. Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine – United States. December 14-23, 2020. MMWR Morb Mortal Wkly Rep. 2021;70(2):46–51.
   PubMed Web of Science ®Google Scholar
• Jaggers J, Samarakoon U, Fu X, Gonzalez-Estrada A, Anvari S, Chong HJ, Van Meerbeke SW, Petrov AA, Chow TG, Banerji A, et al. Anaphylaxis after COVID-19 vaccination: a registry-based study. J Allergy Clin Immunol Pract. 2022;10(11):3020–3023. doi:10.1016/j.jaip.2022.08.008.
   PubMed Web of Science ®Google Scholar
• Sharif N, Alzahrani KJ, Ahmed SN, Dey SK. Efficacy, immunogenicity and safety of COVID-19 vaccines: a systematic review and meta-analysis. Front Immunol. 2021;714170. doi:10.3389/fimmu.2021.714170.
   PubMed Web of Science ®Google Scholar
• Xing K, Tu XY, Liu M, Liang ZW, Chen JN, Li JJ, Jiang LG, Xing FQ, Jiang Y. Efficacy and safety of COVID-19 vaccines: a systematic review. Zhongguo Dang Dai Er Ke Za Zhi. 2021;23(3):221–228.
   PubMedGoogle Scholar
• Song Z, Liu X, Xiang P, Lin Y, Dai L, Guo Y, Liao J, Chen Y, Liang Y, Sun Y. The current status of vaccine uptake and the impact of COVID-19 on intention to vaccination in patients with COPD in Beijing. Int J Chron Obstruct Pulmon Dis 2021;16:3337–3346. doi:10.2147/COPD.S340730.
   PubMed Web of Science ®Google Scholar
• Belingheri M, Roncalli M, Riva MA, Paladino ME, Teruzzi CM. COVID-19 vaccine hesitancy and reasons for or against adherence among dentists. J Am Dent Assoc 2021;152(9):740–746. doi:10.1016/j.adaj.2021.04.020.
   PubMed Web of Science ®Google Scholar
• Burke PF, Masters D, Massey G. Enablers and barriers to COVID-19 vaccine uptake: an international study of perceptions and intentions. Vaccine 2021;39(36):5116–5128. doi:10.1016/j.vaccine.2021.07.056.
   PubMed Web of Science ®Google Scholar
• Alibrahim J, Awad A. COVID-19 vaccine hesitancy among the public in Kuwait: a cross-sectional survey. IJERPH 2021;18(16):8836. doi:10.3390/ijerph18168836.
   Web of Science ®Google Scholar
• Halperin SA, Ye L, MacKinnon-Cameron D, Smith B, Cahn PE, Ruiz-Palacios GM, Ikram A, Lanas F, Lourdes Guerrero M, Muñoz Navarro SR, et al. Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: An international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial. Lancet 2022;399(10321):237–248. doi:10.1016/S0140-6736(21)02753-7.
   PubMed Web of Science ®Google Scholar
• The Chinese Center for Disease Control and Prevention. The monitoring of adverse reactions to COVID-19 vaccination in China, with a total of 31434 cases. Mod. Hosp 2021;21:884.
   Google Scholar
• Agache I, Rocha C, Beltran J, Song Y, Posso M, Solà I, Alonso-Coello P, Akdis C, Akdis M, Canonica GW, et al. Efficacy and safety of treatment with biologicals(benralizumab, dupilumab and omalizumab)for severe allergic asthma: a systematic review for the EAACI guidelines-recommendations on the use of biologicals in severe asthma. Allergy 2020;75(5):1043–1057. doi:10.1111/all.14235.
   PubMed Web of Science ®Google Scholar
• Caminati M, Guarnieri G, Batani V, Scarpieri E, Finocchiaro A, Chieco-Bianchi F, Senna G, Vianello A. COVID-19 vaccination in patients with severe asthma on biologic treatment: safety, tolerability, and impact on disease control. Vaccines 2021;9(8):853. doi:10.3390/vaccines9080853.
   Web of Science ®Google Scholar
• Strestik BD, Olbrich ARM, Hasenkrug KJ, Dittmer U. The role of IL-5, IL-6 and IL-10 in primary and vaccine-primed immune responses to infection with Friend retrovirus (Murine leukaemia virus). J Gen Virol 2001;82(Pt 6):1349–1354. doi:10.1099/0022-1317-82-6-1349.
   PubMed Web of Science ®Google Scholar
• Kühn R, Rajewsky K, Müller W. Generation and analysis of interleukin-4 deficient mice. Science 1991;254(5032):707–710. doi:10.1126/science.1948049.
   PubMed Web of Science ®Google Scholar
• Runnstrom MC, Morrison-Porter A, Ravindran M, Quehl H, Ramonell RP, Woodruff M, Patel R, Kim C, Haddad NS, Lee FE-H, et al. Reduced COVID-19 vaccine response in patients treated with biologic therapies for asthma. Am J Respir Crit Care Med 2022;205(10):1243–1245. doi:10.1164/rccm.202111-2496LE.
   PubMed Web of Science ®Google Scholar
• Earle KA, Ambrosino DM, Fiore-Gartland A, Goldblatt D, Gilbert PB, Siber GR, Dull P, Plotkin SA. Evidence for antibody as a protective correlate for COVID-19 vaccines. Vaccine 2021;39(32):4423–4428. doi:10.1016/j.vaccine.2021.05.063.
   PubMed Web of Science ®Google Scholar
• Caminati M, Vultaggio A, Matucci A, Senna G, Almerigogna F, Bagnasco D, Chieco-Bianchi F, Cosini F, Girelli D, Guarnieri G, et al. Asthma in a large COVID-19 cohort: prevalence, features, and determinants of COVID-19 disease severity. Respir Med. 2021;176:106261. doi:10.1016/j.rmed.2020.106261.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. Global strategy for asthma management and prevention. 2022 update. https://ginasthma.org/wp-content/uploads/2022/05/GINA-Main-Report-2022-FINAL-22-05-03-WMS.pdf.
   Google Scholar